Article List

WPRIM Management System> DCMS> Chinese Journal of Lung Cancer> 2010> 13> 5

Volume: 13 Issue: 5

1. Synchronous lung cancer in operation and brain infraction.	Page:560—562
2. Huge primary pulmonary lymphoma: a report of one case and review of the literature.	Page:557—559
3. Case report: pulmonary typical carcinoid with multi-organ metastasis.	Page:554—556
4. Pleuropulmonary blastoma: a clinicopathological analysis.	Page:550—553
5. Advances on treatment of small cell lung cancer with amrubicin.	Page:544—549
6. Analysis of 41 cases of primary hypervascular non-small cell lung cancer treated with embolization of emulsion of chemotherapeutics and iodized oil.	Page:540—543
7. A systematic review on different treatment methods of bone metastasis from cancers.	Page:533—539
8. The association of XPD G312A polymorphism with lung cancer risk: a meta-analysis.	Page:526—532
9. ERCC1 expression as a predictor of survival after operation in stage I non-small cell lung cancer patients.	Page:522—525
10. Expression of PAH-DNA adducts in lung tissues of Xuanwei female lung cancer patients.	Page:517—521
11. A case-control study on non-smoking primary lung cancers in Sichuan, China.	Page:511—516
12. Association between GSTM1 genetic polymorphism and lung cancer risk by SYBR green I real-time PCR assay.	Page:506—510
13. Clinical value of serum TPS, CEA, Pro-GRP and CYFRA21-1 in patients with lung cancer.	Page:500—505
14. Advanced NSCLC first pass perfusion at 64-slice CT: reproducibility of volume-based quantitative measurement.	Page:494—499
15. Estimation and projection of lung cancer incidence and mortality in China.	Page:488—493
16. Culture of dendritic cells in vitro and its anti-tumor immunotherapy.	Page:483—487
17. Mechanisms of proliferative inhibition by maimendong & qianjinweijing decoction in A549 cells.	Page:477—482
18. Preparation of two types p53 recombinant adenovirus and quantitative exogenous expression of green fluorescence protein by flow cytometry.	Page:470—476
19. The relationship between the TSLC1 silencing and DNA methylation in human lung cancer cells.	Page:464—469
20. Relationship between single nucleotide polymorphism of the equilibrative nucleoside transporter ENT3 and susceptibility to lung cancer.	Page:458—463
21. Defective expression of TGFBR3 gene and its molecular mechanisms in non-small cell lung cancer cell lines.	Page:451—457
22. Diagnostic value of transbronchial needle aspiration and endobronchial ultrasound-guided transbronchial needle aspiration for hilar and mediastinal lymph nodes in lung cancer patients.	Page:447—450
23. Morphology and edge analysis of endobronchial ultrasound images in 47 patients with pulmonary malignant lesions.	Page:443—446
24. Initial experience on endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis and staging of lung cancer.	Page:438—442
25. Role of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma.	Page:432—437
26. Pathological basis of air bronchogram examined by endobronchial ultrasound in patients with peripheral lung cancer.	Page:424—431
27. Endobronchial ultrasound-guided tranbronchial needle aspiration (EBUS-TBNA) in the diagnosis and staging of lung cancer.	Page:418—423
28. Review of the role of EBUS-TBNA for the pulmonologist, including lung cancer staging.	Page:410—417
29. Application of real time endobronchial ultrasound-guided transbronchial needle aspiration for lung cancer staging.	Page:406—409
30. Endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging of lung cancer and diagnosis of intrathoracic lesions.	Page:403—405
31. Role of EBUS-TBNA for mediastinal lymph node staging of lung cancer.	Page:401—402
32. The role of TBNA in diagnosis and treatment of lung diseases.	Page:396—400
33. Recent developments and perspectives of endobronchial ultrasound in thoracic tumor.	Page:393—395
34. To promote the clinical application of endobronchial ultrasound-guided transbronchial needle aspiration in China.	Page:391—392